Allarity Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsOct 1 →InsidersNo open-market buys or sales.→HoldersRenaissance Technologies 2.1%Vanguard 1.1%Geode 1.0%→Financing →PeersClosest companies: IDYA, APRE, ACRV→
From the filings
Figures
- Revenue
- $345,000last 12 months
- Net income
- −$12.3Mlast 12 months
- Operating cash flow
- −$16.6Mlast 12 months
- Cash and equivalents
- $17.0Mat the last balance sheet
- Total debt
- $20.9Mat the last balance sheet
- Shares outstanding
- 15.9M shareson issue